α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma

Published on Aug 1, 2018in Acta Biomaterialia7.242
· DOI :10.1016/J.ACTBIO.2018.06.029
Vanessa Sainz4
Estimated H-index: 4
(UCL: University College London),
Liane I.F. Moura14
Estimated H-index: 14
(University of Hertfordshire)
+ 11 AuthorsHelena F. Florindo21
Estimated H-index: 21
(University of Lisbon)
Sources
Abstract
Abstract α-Galactosylceramide (GalCer) is a glycolipid widely known as an activator of Natural killer T (NKT) cells, constituting a promising adjuvant against cancer, including melanoma. However, limited clinical outcomes have been obtained so far. This study evaluated the synergy between GalCer and major histocompatibility complex (MHC) class I and MHC class II melanoma-associated peptide antigens and the Toll-Like Receptor (TLR) ligands CpG and monophosphoryl lipid A (MPLA), which we intended to maximize following their co-delivery by a nanoparticle (NP). This is expected to improve GalCer capture by dendritic cells (DCs) and subsequent presentation to NKT cells, simultaneously inducing an anti-tumor specific T-cell mediated immunity. The combination of GalCer with melanoma peptides and TLR ligands successfully restrained tumor growth. The tumor volume in these animals was 5-fold lower than the ones presented by mice immunized with NPs not containing GalCer. However, tumor growth was controlled at similar levels by GalCer entrapped or in its soluble form, when mixed with antigens and TLR ligands. Those two groups showed an improved infiltration of T lymphocytes into the tumor, but only GalCer-loaded nano-vaccine induced a prominent and enhanced infiltration of NKT and NK cells. In addition, splenocytes of these animals secreted levels of IFN-γ and IL-4 at least 1.5-fold and 2-fold higher, respectively, than those treated with the mixture of antigens and adjuvants in solution. Overall, the combined delivery of the NKT agonist with TLR ligands and melanoma antigens via this multivalent nano-vaccine displayed a synergistic anti-tumor immune-mediated efficacy in B16F10 melanoma mouse model. Statement of Significance Combination of α-galactosylceramide (GalCer), a Natural Killer T (NKT) cell agonist, with melanoma-associated antigens presented by MHC class I (Melan-A:26) and MHC class II (gp100:44) molecules, and Toll-like Receptor (TLR) ligands (MPLA and CpG), within nanoparticle matrix induced a prominent anti-tumor immune response able to restrict melanoma growth. An enhanced infiltration of NKT and NK cells into tumor site was only achieved when the combination GalCer, antigens and TLR ligands were co-delivered by the nanovaccine.
📖 Papers frequently viewed together
9 Authors (Yusuf Dolen, ..., Carl G. Figdor)
44 Citations
4 Citations
42 Citations
References54
Newest
#1Reem Ghinnagow (French Institute of Health and Medical Research)H-Index: 3
#2Julie De Meester (French Institute of Health and Medical Research)H-Index: 1
Last. François Trottein (French Institute of Health and Medical Research)H-Index: 55
view all 15 authors...
ABSTRACTVaccines designed to abrogate the tolerance of tumor self-antigens and amplify cytotoxic CD8+ T cells (CTLs) have promise for the treatment of cancer. Type I natural killer (NKT) cells have attracted considerable interest in the cancer therapy field. In the current study, we have exploited the unique ability of NKT cells to serve as T-helper cells to license dendritic cells (DCs) for cross priming with the aim to generate efficient CTL antitumor responses. To this end, we designed a nano...
25 CitationsSource
#1Eva Zupancic (Weizmann Institute of Science)H-Index: 7
#2Caterina Curato (Weizmann Institute of Science)H-Index: 6
Last. Helena F. Florindo (University of Lisbon)H-Index: 21
view all 13 authors...
Vaccination is a promising strategy to trigger and boost immune responses against cancer or infectious disease. We have designed, synthesized and characterized aliphatic-polyester (poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NP) to investigate how the nature of protein association (adsorbed versus entrapped) and polymer/surfactant concentrations impact on the generation and modulation of antigen-specific immune responses. The ability of the NP formulations to target dendritic cells (DC),...
46 CitationsSource
#1Mary Speir (Malaghan Institute of Medical Research)H-Index: 10
#2Ian F. Hermans (Victoria University of Wellington)H-Index: 32
Last. Robert Weinkove (University of Otago)H-Index: 18
view all 3 authors...
Conventional vaccine adjuvants enhance peptide-specific T-cell and B-cell responses by modifying peptide stability or uptake or by binding to pattern-recognition receptors on antigen-presenting cells (APCs). This article discusses the application of a distinct mechanism of adjuvant activity: the activation of type I, or invariant, natural killer T (iNKT) cells to drive cellular and humoral immune responses. Using a semi-invariant T-cell receptor (TCR), iNKT cells recognize glycolipid antigens pr...
17 CitationsSource
#1Vanessa Sainz (UCL: University College London)H-Index: 4
#2Carina Peres (University of Lisbon)H-Index: 7
Last. João A. Lopes (University of Lisbon)H-Index: 16
view all 12 authors...
This paper discusses the development of a multivariate-based regression model for estimating the critical attributes to establish a design-space for poly(lactic-co-glycolic acid) (PLGA) nanoparticles formulated by a double emulsion–solvent evaporation method. A three-level, full factorial experimental design is used to assess the impact of three different manufacturing conditions (polymer viscosity, surfactant concentration and amount of model antigen ovalbumin) on five critical particle attribu...
4 CitationsSource
#1Yusuf Dolen (Radboud University Nijmegen)H-Index: 9
#2Martin Kreutz (Radboud University Nijmegen)H-Index: 6
Last. Carl G. Figdor (Radboud University Nijmegen)H-Index: 125
view all 9 authors...
Antitumor immunity can be enhanced by the coordinated release and delivery of antigens and immune-stimulating agents to antigen-presenting cells via biodegradable vaccine carriers. So far, encapsulation of TLR ligands and tumor-associated antigens augmented cytotoxic T cell (CTLs) responses. Here, we compared the efficacy of the invariant NKT (iNKT) cell agonist α-galactosylceramide (α-GalCer) and TLR ligands (R848 and poly I:C) as an adjuvant for the full length ovalbumin (OVA) in PLGA nanopart...
44 CitationsSource
#1Simon Gebremeskel (Dal: Dalhousie University)H-Index: 12
#2Drew Slauenwhite (Dal: Dalhousie University)H-Index: 5
Last. Brent JohnstonH-Index: 34
view all 3 authors...
Natural killer T (NKT) cells are glycolipid-reactive T lymphocytes that function in immunosurveillance and immune regulation. However, reduced tumor control in NKT cell-deficient Jα18−/− mice may be confounded by an overall reduction in T-cell receptor (TCR) repertoire diversity in these animals. Mechanistic studies are also hindered by a lack of tools to target molecules specifically in NKT cells. To address these issues, we developed protocols to expand functional NKT cells and stably reconsti...
7 CitationsSource
#1Yun Hu (VT: Virginia Tech)H-Index: 11
#2Reece Hoerle (VT: Virginia Tech)H-Index: 3
Last. Chenming Zhang (VT: Virginia Tech)H-Index: 27
view all 4 authors...
Abstract Lipid–polymer hybrid nanoparticles (NPs), consisting of a polymeric core and a lipid shell, have been intensively examined as delivery systems for cancer drugs, imaging agents, and vaccines. For applications in vaccine particularly, the hybrid NPs need to be able to protect the enclosed antigens during circulation, easily be up-taken by dendritic cells, and possess good stability for prolonged storage. However, the influence of lipid composition on the performance of hybrid NPs has not ...
39 CitationsSource
#1Silke Neumann (University of Otago)H-Index: 7
#2Katie Young (University of Otago)H-Index: 4
Last. Sarah Hook (University of Otago)H-Index: 29
view all 6 authors...
The lipid antigen α-galactosylceramide (α-GalCer) is a potent activator of invariant natural killer T-cells (iNKT cells) and can stimulate cytotoxic and anti-tumour immune responses. However optimal responses appear to be induced by α-GalCer when cell-based vaccines are delivered intravenously. Here we investigated if co-delivery of protein and peptide antigens along with α-GalCer in a liposomal formulation could stimulate therapeutic anti-tumour immune responses. Cationic liposomes were inheren...
27 CitationsSource
#1Naveen K. Mehta (MIT: Massachusetts Institute of Technology)H-Index: 9
#2Kelly D. Moynihan (MIT: Massachusetts Institute of Technology)H-Index: 13
Last. Darrell J. IrvineH-Index: 88
view all 3 authors...
Recently, a number of promising approaches have been developed using synthetic chemistry, materials science, and bioengineering-based strategies to address challenges in the design of more effective cancer vaccines. At the stage of initial priming, potency can be improved by maximizing vaccine delivery to lymph nodes. Because lymphatic uptake from peripheral tissues is strongly size dependent, antigens and adjuvants packaged into optimally sized nanoparticles access the lymph node with much grea...
41 CitationsSource
#1Catherine Gottschalk (University of Bonn)H-Index: 6
#2Elisabeth Mettke (University of Bonn)H-Index: 2
Last. Christian Kurts (University of Bonn)H-Index: 73
view all 3 authors...
New vaccination strategies focus on achieving CD8+ T cell (CTL) immunity rather than on induction of protective antibody responses. While the requirement of CD4+ T (Th) cell help in dendritic cell (DC) activation and licensing, and in CTL memory induction has been described in several disease models, CTL responses may occur in a Th cell help independent manner. Natural Killer T cells (NKT cells) can substitute for Th cell help and license DC as well. NKT cells produce a broad spectrum of Th1 and...
30 CitationsSource
Cited By12
Newest
#1Wenqiang Chen (WMU: Weifang Medical University)
#2Jiang Mingxia (WMU: Weifang Medical University)
Last. Weifen Zhang (WMU: Weifang Medical University)H-Index: 12
view all 8 authors...
Cancer has been a serious health hazard to the people all over the world with its high incidence and horrible mortality. In recent years, tumor vaccines in immunotherapy have become a hotspot in cancer therapy due to their many practical advantages and good therapeutic potentials. Among the various vaccines, nanovaccine utilized nanoparticles (NPs) as the carrier and/or adjuvant has presented significant therapeutic effect in cancer treatment. For tumor nanovaccines, unmethylated cytosine-phosph...
Source
#1Anubhab MukherjeeH-Index: 13
#2Vijay Sagar Madamsetty (Mayo Clinic)H-Index: 8
Last. Sudip Mukherjee (Rice University)H-Index: 24
view all 3 authors...
Abstract Recently, immunomodulatory nanomaterials have gained immense attention due to their involvement in the modulation of the body’s immune response to cancer therapy. This book highlights vari...
#1Lun Yao (HAU: Huazhong Agricultural University)
#2Qiao Hu (HAU: Huazhong Agricultural University)
Last. Qigai He (HAU: Huazhong Agricultural University)H-Index: 25
view all 10 authors...
Abstract Owing to viral recombination, interspecies transmission, and evolution, variant pseudorabies virus (PRV) strains exhibit different biological characteristics and pathogenicity. To improve the understanding of common and specific metabolic changes that occur upon infection by different PRV strains, we herein describe the comprehensive analysis of metabolites of PRV vaccine strain (Bartha K61), classical strain (EA) and variant strain (HNX) infection in immortalized porcine alveolar macro...
Source
#1Carina Peres (University of Lisbon)H-Index: 7
#1Carina Peres (IMM: Instituto de Medicina Molecular)
Last. Helena F. Florindo (University of Lisbon)H-Index: 21
view all 10 authors...
Abstract The remarkable success of targeted immunotherapies is revolutionizing cancer treatment. However, tumor heterogeneity and low immunogenicity, in addition to several tumor-associated immunosuppression mechanisms are among the major factors that have precluded the success of cancer vaccines as targeted cancer immunotherapies. The exciting outcomes obtained in patients upon the injection of tumor-specific antigens and adjuvants intratumorally, reinvigorated interest in the use of nanotechno...
Source
#1Olivia K. Burn (Malaghan Institute of Medical Research)H-Index: 1
#2T E Pankhurst (Victoria University of Wellington)
Last. Ian F. Hermans (Malaghan Institute of Medical Research)H-Index: 32
view all 5 authors...
Source
#1Harrison Y. R. Madge (UQ: University of Queensland)H-Index: 1
#2Rachel J. Stephenson (UQ: University of Queensland)H-Index: 8
Last. Istvan Toth (UQ: University of Queensland)H-Index: 61
view all 3 authors...
Abstract Vaccination is one of the most effective public health interventions for prevention and treatment of diseases. However, there are certain unfavorable characteristics associated with whole pathogen live attenuated/heat killed and protein subunit vaccines. Most notably, there exists numerous diseases for which these classical vaccination methods are either ineffective or unsafe, for example, cancer, human immunodeficiency virus, and group A streptococcus. As a result of this need for impr...
Source
#1Sahra Bashiri (UQ: University of Queensland)H-Index: 1
#2Prashamsa Koirala (UQ: University of Queensland)H-Index: 1
Last. Mariusz Skwarczynski (UQ: University of Queensland)H-Index: 32
view all 4 authors...
Modern subunit vaccines are composed of antigens and a delivery system and/or adjuvant (immune stimulator) that triggers the desired immune responses. Adjuvants mimic pathogen-associated molecular patterns (PAMPs) that are typically associated with infections. Carbohydrates displayed on the surface of pathogens are often recognized as PAMPs by receptors on antigen-presenting cells (APCs). Consequently, carbohydrates and their analogues have been used as adjuvants and delivery systems to promote ...
4 CitationsSource
#1Shuyao Lang (MSU: Michigan State University)H-Index: 5
#2Xuefei Huang (MSU: Michigan State University)H-Index: 39
Vaccines are powerful tools that can activate the immune system for protection against various diseases. As carbohydrates can play important roles in immune recognition, they have been widely applied in vaccine development. Carbohydrate antigens have been investigated in vaccines against various pathogenic microbes and cancer. Polysaccharides such as dextran and beta-glucan can serve as smart vaccine carriers for efficient antigen delivery to immune cells. Some glycolipids, such as galactosylcer...
13 CitationsSource
#1Maria L Guevara (Children's Hospital of Eastern Ontario)H-Index: 1
#2Zachary Jilesen (Children's Hospital of Eastern Ontario)H-Index: 1
Last. Stefano Persano (IIT: Istituto Italiano di Tecnologia)H-Index: 1
view all 4 authors...
Recently, the use of mRNA-based vaccines for cancer immunotherapy has gained growing attention. Several studies have shown that mRNA delivered in a vectorized format can generate a robust and efficient immune response. In this work, a new lipopolyplex vector (multi-LP), incorporating the immune adjuvant α-galactosylceramide (α-GalCer) and a multivalent cationic lipid, was proposed for the in vivo delivery of mRNA into antigen-presenting cells. We demonstrate that dendritic cells (DCs) can be tar...
15 CitationsSource
#1Manyi Wang (Sichuan University)H-Index: 2
#2Sijia Li (Sichuan University)H-Index: 2
Last. Xian Jiang (Sichuan University)H-Index: 9
view all 7 authors...
: Cutaneous melanoma is one of the most common malignant skin tumors and advanced melanoma is usually associated with a poor prognosis. In the current study, we demonstrated the tumor suppressing role of epithelial membrane protein-2 (EMP2) by inducing apoptosis in a A375 human melanoma cell line. Mechanistically, the low expression of EMP2 in melanoma is partially due to autophagic protein degradation mediated by the mTOR pathway. These results suggest there is regulation of autophagy as well a...
3 CitationsSource